Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Gastroenterology

The Diagnostic Roadmap: Understanding Your PDAI Score and Pathology Report

At a Glance

Pouchitis is officially diagnosed using the Pouchitis Disease Activity Index (PDAI), an 18-point scale evaluating clinical symptoms, visual endoscopy findings, and microscopic biopsy results. A total PDAI score of 7 or higher is required to confirm active inflammation in the pouch.

A diagnosis of pouchitis is not based on symptoms alone. Because symptoms like urgency and frequency can overlap with other conditions, doctors use a standardized “math-based” approach to confirm if the pouch is truly inflamed [1][2].

The gold standard for this diagnosis is the Pouchitis Disease Activity Index (PDAI) [3]. This system combines three different “viewpoints” to create a total score that reflects the objective health of your pouch [4].

The PDAI Scoring System

The PDAI is an 18-point scale divided into three categories, each worth up to 6 points [5]:

  1. Clinical Symptoms: Your daily experience (stool frequency, urgency, fever, and bleeding) [5].
  2. Endoscopic Findings: What the doctor sees during a pouchoscopy (a camera exam of the pouch) [6].
  3. Histologic Findings: What the pathologist sees under the microscope from your biopsies [7].

A total score of 7 or higher is the standard threshold used to officially diagnose active pouchitis [3][8]. If your score is high in the symptom category but low in the endoscopic and histologic categories, your doctor may look for non-inflammatory causes like Irritable Pouch Syndrome (IPS) [2][9].

What the Doctor Sees (Endoscopy)

During a pouchoscopy, your gastroenterologist isn’t just taking a quick look at the pouch; they are looking for specific signs of tissue distress [10]. Key features that contribute to your PDAI score include:

  • Edema: Swelling of the pouch lining [11].
  • Friability: Tissue that bleeds easily when brushed or touched by the camera [11].
  • Granularity: A rough, “sandpaper” appearance rather than a smooth, healthy lining [11].
  • Loss of Vascular Pattern: The inability to clearly see the normal branching blood vessels through the lining [11].
  • Ulceration: Small sores or pits in the tissue [6].

What the Pathologist Sees (Histology)

When biopsies are taken, a pathologist looks for microscopic evidence of your immune system being in “attack mode” [12]. They specifically look for:

  • Polymorphonuclear Leukocytes (Neutrophils): These are white blood cells that rush to the site of acute inflammation [13].
  • Crypt Abscesses: Collections of these white blood cells inside the small “pits” (crypts) of the intestinal lining [13].
  • Erosion or Ulceration: Direct damage to the surface layer of the cells [13].

Your Report Completeness Checklist

To ensure your diagnosis is accurate, your medical reports should be exceptionally thorough. When you review your records on your patient portal, check for these elements:

  • [ ] Anatomical Landmarks: Does the report mention the afferent limb (the small bowel above the pouch), the pouch body, and the rectal cuff? [10][14]
  • [ ] Biopsy Locations: Were samples taken from both the pouch itself and the small bowel immediately above it? [13]
  • [ ] Granulomas: The report should state if these were present or absent, as they can point toward a Crohn’s diagnosis rather than standard idiopathic pouchitis [15][16].
  • [ ] PDAI Score: While not always written as a single combined number, the report should provide enough detail for you and your doctor to calculate the score [17].

Common questions in this guide

What is a PDAI score for pouchitis?
The Pouchitis Disease Activity Index (PDAI) is an 18-point scoring system used to diagnose pouchitis. It combines your daily symptoms, visual findings from a pouchoscopy, and microscopic biopsy results. A total score of 7 or higher typically confirms active pouchitis.
What does it mean if my pouchoscopy shows friability or granularity?
Friability and granularity are signs of tissue distress in the pouch. Friability means the tissue bleeds easily when touched by the endoscope, while granularity indicates a rough, sandpaper-like appearance instead of a normal, smooth lining.
Why does my pathology report mention crypt abscesses?
Crypt abscesses are collections of white blood cells found inside the small pits of your intestinal lining. Their presence on a biopsy indicates that your immune system is actively causing microscopic inflammation, which is a key marker for pouchitis.
Can I have pouchitis symptoms without actually having pouchitis?
Yes, it is possible to experience severe symptoms like frequency and urgency but have normal endoscopic and biopsy results. In these cases, doctors often suspect non-inflammatory conditions like Irritable Pouch Syndrome (IPS) rather than active pouchitis.
Why is my doctor checking for granulomas in my pouch biopsies?
Pathologists look for granulomas because their presence can point toward a diagnosis of Crohn's disease rather than standard idiopathic pouchitis. Finding granulomas helps your medical team determine the precise underlying cause of your pouch inflammation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my total PDAI score, and how did the three subscores (symptoms, endoscopy, and histology) compare to each other?
  2. 2.Did you see any signs of 'cuffitis' or inflammation in the 'afferent limb' (the small bowel just above the pouch)?
  3. 3.Were 'granulomas' found in any of my biopsy samples?
  4. 4.My symptoms are significant, but if my endoscopic score was low, what could be causing the discrepancy?
  5. 5.Does the pathology report show 'crypt abscesses' or deep ulcerations?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Prevalence of Active Pouch Symptoms and Patient Perception of Symptom Control and Quality of Life in an Outpatient Practice.

    Kirsch P, Rauch J, Delau O, et al.

    Gastro hep advances 2024; (3(8)):1069-1078 doi:10.1016/j.gastha.2024.07.019.

    PMID: 39529641
  2. 2

    Determinants of Pouch-Related Symptoms, a Common Outcome of Patients With Adenomatous Polyposis Undergoing Ileoanal Pouch Surgery.

    Gilad O, Gluck N, Brazowski E, et al.

    Clinical and translational gastroenterology 2020; (11(10)):e00245 doi:10.14309/ctg.0000000000000245.

    PMID: 33031194
  3. 3

    Serum alpha-1 antitrypsin: a noninvasive marker of pouchitis.

    Matalon S, Elad H, Brazowski E, et al.

    Inflammatory bowel diseases 2015; (21(3)):589-95 doi:10.1097/MIB.0000000000000308.

    PMID: 25659085
  4. 4

    Prevention and Medical Treatment of Pouchitis In Ulcerative Colitis.

    Benlice C, Shen B, Steele SR

    Current drug targets 2019; (20(13)):1399-1408 doi:10.2174/1389450120666190723130137.

    PMID: 31333137
  5. 5

    Mucosa-Associated Microbiota in Ileoanal Pouches May Contribute to Clinical Symptoms, Particularly Stool Frequency, Independent of Endoscopic Disease Activity.

    Turpin W, Kelly O, Borowski K, et al.

    Clinical and translational gastroenterology 2019; (10(5)):1-7 doi:10.14309/ctg.0000000000000038.

    PMID: 31117112
  6. 6

    Endoscopic activity in asymptomatic patients with an ileal pouch is associated with an increased risk of pouchitis.

    Kayal M, Plietz M, Radcliffe M, et al.

    Alimentary pharmacology & therapeutics 2019; (50(11-12)):1189-1194 doi:10.1111/apt.15505.

    PMID: 31579976
  7. 7

    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosis.

    Barreiro-de Acosta M, Gutierrez A, Rodríguez-Lago I, et al.

    Gastroenterologia y hepatologia 2019; (42(9)):568-578 doi:10.1016/j.gastrohep.2019.08.001.

    PMID: 31606162
  8. 8

    Fecal Calprotectin Is Increased in Pouchitis and Progressively Increases With More Severe Endoscopic and Histologic Disease.

    Ollech JE, Bannon L, Maharshak N, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022; (20(8)):1839-1846.e2 doi:10.1016/j.cgh.2021.11.012.

    PMID: 34798336
  9. 9

    MRI defecography of the ileal pouch-anal anastomosis-contributes little to the understanding of functional outcome.

    Sunde ML, Negård A, Øresland T, et al.

    International journal of colorectal disease 2018; (33(5)):609-617 doi:10.1007/s00384-018-3011-0.

    PMID: 29520456
  10. 10

    Endoscopic Evaluation of the Ileal Pouch.

    Shen B

    Diseases of the colon and rectum 2024; (67(S1)):S52-S69 doi:10.1097/DCR.0000000000003269.

    PMID: 38276962
  11. 11

    Development of a convolutional neural network for the endoscopic classification of pouchitis in patients after restorative proctocolectomy.

    Saifi M, Eisenmann U, Ringwald F, et al.

    Techniques in coloproctology 2026; (30(1)).

    PMID: 41845084
  12. 12

    Inflammatory bowel disease-specific findings are common morphological changes in the ileal pouch with ulcerative colitis.

    Toritani K, Kimura H, Otani M, et al.

    Scientific reports 2022; (12(1)):20361 doi:10.1038/s41598-022-24708-2.

    PMID: 36437274
  13. 13

    Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium.

    Shen B, Kochhar GS, Rubin DT, et al.

    The lancet. Gastroenterology & hepatology 2022; (7(1)):69-95 doi:10.1016/S2468-1253(21)00214-4.

    PMID: 34774224
  14. 14

    Computed tomography-guided endoscopic sinusotomy for an ileal pouch presacral sinus.

    El Ouali S, Veniero JC, Shen B

    Endoscopy 2018; (50(7)):730-731 doi:10.1055/a-0596-7107.

    PMID: 29742765
  15. 15

    A pragmatic stepwise approach to the diagnosis and management of refractory acute pouchitis.

    Ardalan ZS, Sparrow MP

    Expert opinion on pharmacotherapy 2021; (22(5)):531-533 doi:10.1080/14656566.2021.1882422.

    PMID: 33538185
  16. 16

    Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU.

    Mesonero F, Zabana Y, Fernández-Clotet A, et al.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2025; (57(2)):566-573 doi:10.1016/j.dld.2024.09.023.

    PMID: 39455313
  17. 17

    Endoscopic assessment of the J pouch in ulcerative colitis: A narrative review.

    Akiyama S, Barnes EL, Onoda T, et al.

    DEN open 2025; (5(1)):e373 doi:10.1002/deo2.373.

    PMID: 38694540

This guide to understanding the PDAI score and pouchitis pathology is for educational purposes only. Always review your specific pouchoscopy and biopsy results with your gastroenterologist.

Get notified when new evidence is published on Pouchitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.